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Reassessing Impacts of Extended 
Daily Exposure to Low Level Solar 
UV Radiation
Richard L. McKenzie  1 & Robyn M. Lucas  2
Currently, health agencies recommend that no sun-protection is required when the UV Index (UVI) is 
less than 3. We use high-quality data from spectroradiometers and model calculations to demonstrate 
that this simplification is seriously flawed, particularly for mid-latitude conditions. For days when the 
peak UVI is below the threshold for advising protection, the daily dose of sun-burning UV available 
frequently far exceeds the threshold for damage to fair skin. This may have important health 
consequences, as populations at mid latitudes include a significant proportion with fair skin that is 
susceptible to damage.
Information on the risks of sun exposure is usually communicated to the public in terms of the UV Index (UVI), 
which is a measure of “sun-burning” (i.e., erythemally-weighted) UV irradiance (UVEry) incident on a horizontal 
surface1. When UVEry is measured in units of Wm−2, the UVI is then simply 40x UVEry2. Thus, the UVI is a meas-
ure of the rate of deposition of energy, or in other words, the power. Currently, WHO INTERSUN recommend 
that ‘no protection is necessary’ when the UVI is less than 32. Some agencies go on to define a “UV Alert” period 
as the period of the day during which the UVI is three or more, again implying that no protection is required 
when the UVI is less than 3.
Such messages, that are based only on UVI1 (i.e. irradiance), rather than UVI and duration, are flawed, and 
potentially contribute to increased health risks. The problem arises because skin damage is a function of the dose 
of UV (i.e., the energy, measured in Joules) rather than the dose rate (i.e., the power, measured in Watts (or Joules 
per second)). The ‘UVI equals 3′ threshold corresponds to the dose rate for which damage to fair skin would take 
approximately 1 hour. Taking a UVI of less than 3 as a threshold for no sun protection presumes that nobody 
will stay in the sunlight for more than an hour: a presumption that is quite arbitrary, and clearly incorrect. For 
example, golf is one of the world’s most popular sports, and it typically takes about 4 hours to complete a round.
The dose of erythemally weighted UV radiation can be expressed in terms of the number of Standard 
Erythemal Doses (SEDs), where 1 SED = 100 Jm−2. For fair skinned individuals, the dose required to elicit vis-
ible damage, as indicated by the first signs of skin reddening 24 hours after exposure, is typically around 2.0 to 
2.5 SED1. In other words, for fair skinned individuals, the dose required to achieve a minimum sunburn (the 
Minimum Erythemal Dose (MED)) is about 2.5 SED. Furthermore, it has been demonstrated that the damaging 
effect of exposure to a larger UVI value for a short time, is similar to that from a low UVI value for a commen-
surately longer time3. For example, the skin damaging effect of 2.5 SED from UVI = 15 for about 11 minutes is 
similar to that for UVI = 1.5 for 110 minutes. That is: reciprocity holds between dose rate (UVI) and time. The 
study quoted shows that reciprocity in erythema applies for exposure times from 1 second to 1 hour. Little work 
has been done for lower dose rates (e.g., UVI < 3), where it could be argued that repair mechanisms may be able 
cope adequately. However, a recent study showed an approximately linear increase in epidermal DNA damage 
(as measured by cyclobutane pyrimidine dimers (CPDs) in skin biopsies) for doses in the range 0.2 to 1.0 MED4.
Method
We investigated the relationship between the peak daily UVI and the cumulative daily dose in SEDs using data 
from multiple measurements each day, taken with UV spectroradiometer systems that meet the demanding 
standards required by the Network for the Detection of Atmospheric Composition Change (NDACC)5. Each 
spectrum takes approximately 7 minutes to acquire, and represents the average of a forward-scan and a reverse 
scan over the wavelength range 285–450 nm. Spectra are taken at 15-minute intervals over the 2.5-hour period 
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centred on local solar noon, and at 5-degree steps in solar zenith angle outside that range. Typically, this provides 
25 to 30 spectra per day. These data are available on the NDACC web site, at http://www.ndsc.ncep.noaa.gov/
UVSpect_web/. Corresponding calculations for clear-sky conditions were also undertaken using the TUV radi-
ative transfer model6.
Results
The variability of peak UVI and daily dose in SEDs over the course of a year at a pristine mid-latitude site, Lauder 
New Zealand (45°S, 170°E, alt: 370 m) is shown in Fig. 1. The data are from approximately 9000 days for which 
there were sufficient data to allow valid estimates of daily doses over the 25-year period dating from the 1990s 
to the present. Over that period, no significant trends in UVI, e.g. as a result of stratospheric ozone depletion or 
changes in air quality, have been detected at this site7.
In summer at this site, the peak UVI measured during the ~5-minute scan period can exceed 14, and the 
peak daily dose can exceed 75 SED. Thus, over the course of a summer’s day there is sufficient sun-burning UV 
radiation to cause 30 erythemal doses (i.e., 30 MEDs) for fair skin (and this in turn means that if a sunscreen is 
to provide “all day” protection, it must, by definition, have an SPF greater than 30). Even on the shortest day in 
mid-winter at this site, when the peak UVI for clear skies is only ~1, the daily dose is still close to ~4 SED. And 
over the winter months of June, July, and August, the mean of the peak daily UVI is 1.25, and the mean daily dose 
is 4.85 SED. Thus, on the average winter day at this site there are nearly 2 MEDs available.
Figure 2 shows the daily dose of erythemally-weighted irradiance (in SEDs) as a function of the peak UVI that 
day. The plot shows that there are very few days for which the daily dose is less than 2.5 SED (=1 MED for fair 
skin): approximately only one day per year. Of note here, is the large proportion of days for which the peak UVI 
is less than 3, yet the daily dose is greater than 2.5 SED. In fact, the figure shows that the damage threshold for 
fair skin is exceeded on virtually all days, including those for which the peak UVI is in the range 0.5 to 3.0. There 
are frequent days for which the UVI is less than 3, yet the daily dose exceeds 10 SEDs, and on a few occasions, it 
reaches 15 SEDs (Table 1).
Figure 1. Annual variability of peak UVI and daily dose in SEDs measured at Lauder New Zealand.
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Similar spectroradiometer systems are deployed at other sites, covering a wide range of latitudes (e.g., 
Melbourne (38°S) and Alice Springs (20°S), in Australia; and Boulder CO (40°N) and Mauna Loa Observatory 
Hawaii (20°N), in USA). All sites exhibit similar patterns (see Fig. S1, in the Supplementary Data), with daily 
doses at the mid-latitude sites frequently exceeding 10 SED when the peak UVI remains less than 3. At the trop-
ical sites (Mauna Loa and Alice Springs) there are only a small number of days for which the UVI is less than 3, 
but the daily doses on those days still usually exceed the visible skin damage threshold by at least a factor of 3.
Table 1 shows that at Lauder, the peak UVI is less than 3 for about 146 days each year, but the daily dose is 
less than 2.5 SED on only 13 of those days. On the other 133 days, erythema can occur with sufficient duration of 
exposure, so the advice that ‘no protection is required’ is misleading. Indeed, on 72 of those days, more than two 
MEDs are possible. We note that in mid-winter at Lauder (45°S), there are only 8.5 daylight hours, and that 50% 
of the daily erythemal dose falls within the 2.5-hour period centred on local solar noon. Consequently, if the daily 
dose exceeds 5 SED, then an erythemal dose is possible within 2.5 hours for exposure periods centred on solar 
noon. When the maximum daily dose exceeds 10 SED, visible skin damage can occur in little more than 1 hour 
in a fair-skinned person.
The statistics for a range of sites show that this flaw in advice, whereby sunburn is easily achievable when the 
UVI is <3 and no protection is advised, is mainly a mid-latitude problem. The issue is less important in the winter 
at higher latitudes, such as Northern Europe (e.g., Germany, UK)8,9, where the peak UVI is less than 1, and, from 
the relationships demonstrated here (Fig. S1), daily UV doses will generally be less than 2.5 SED for much of the 
winter. However, similar issues will arise in the shoulder seasons when the peak values approach UVI = 3.
Although spectroradiometers provide the most accurate UVI measurements available10, their disadvantage is 
that continuous measurements are not possible; and with typically only 20–30 spectra per day, uncertainties can 
result from the daily variation from spectroradiometer data being under-sampled in time. We estimate that the 
uncertainties in daily dose could be as large as 10% for a single day, which would translate to uncertainties of ±7 
days in the last 2 columns of Table 1.
Figure 2. Daily dose of erythemally-weighted UV as a function of the peak UVI measured at Lauder New 
Zealand. The blue point shows the mean SED for UVI = 3, calculated for clear skies at Lauder.
Site Lat UVI ≥ 3
UVI < 3
All 
SED
Daily Dose <1 MED
(no. erythema possible)
Daily Dose >1 MED
(erythema possible)
Daily Dose >2 MED
(erythema possible In <2.5 hours)
Lauder, NZ −45 219 146 13 133 72
Melbourne, Aus. −38 239 126 2 124 101
Alice Springs, Aus. −20 360 5 0 4 4
Mauna Loa, HI 20 365 0 0 0 0
Boulder, CO 40 258 107 5 102 86
Table 1. Approximate number of days per year, based on multi-year data from several sites, for UVI ≥ 3 and 
UVI < 3, with the latter subdivided according to daily MED values, where 1 MED is taken as 2.5 SED.
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To investigate further whether this is an issue, we used the TUV radiative transfer model6, to calculate UVI at 
1 minute intervals and then integrated these results over time to calculate the UV daily dose, in SEDs, as a func-
tion of the peak daily UVI for clear sky conditions. Calculations were performed for a ~12-year period at Lauder, 
representing approximately 4400 days.
These calculations show excellent agreement with the measurements. Calculated values closely follow the 
upper envelope of data in Fig. 2 that correspond to clear-sky days. For a given peak daily UVI, the daily doses can 
vary by ±5–10 percent, due to differences in day-length and ozone amount. To avoid clutter, the calculated value 
is shown only for the UVI = 3 threshold value, for which the mean calculated daily dose is 13.4 SED, with a range 
from 12.5 to 14.3 SED. The calculations confirm that for clear-skies at Lauder, the daily dose can exceed 14 SED 
when the peak UVI is less than 3 and can exceed 11 SED when the peak UVI is less than 2.5. In the former case, 
mild erythema could result from exposure periods of approximately 1 hour near solar noon.
Discussion
We have shown that information provided to the public on sun protection is flawed. The findings are particularly 
relevant for mid-latitude conditions. For days when the peak UVI is below the threshold for advising protection, 
the daily dose of sun-burning UV available frequently far exceeds the threshold for visible damage to fair skin. 
Furthermore, the damaging UV received on exposed surfaces, such as the face or neck, may be more pronounced 
than implied from these measurements of UVI during winter, because when the sun is lower in the sky, the UV 
incident on such surfaces can be significantly greater than on a horizontal surface. The head and neck are the body 
sites for which skin damage from sunlight is most pronounced.
This incorrect advice to the public may have important public health consequences. The frequency of days with 
peak UVI less than 3, but with daily doses exceeding the threshold for damage is largest at the three mid-latitude 
sites considered. For each of these sites, the dose on days in which the peak UVI is less than 3 represents approx-
imately 10% of the total annual dose. In contrast, at the two low-latitude sites, the contribution from days with 
UVI < 3 is less than 1% of the total. In the limit, at the highest northern latitudes, the peak UVI is always less than 
311, and 100% of the total annual dose is received on days with the peak UVI less than 3 (though in this case, the 
daily total dose will usually be below the threshold for damage).
Populations at mid latitudes include a significant proportion with fair skin that is susceptible to UV damage. 
Because ‘no protection’ is advised, precautions against sunburn are unlikely to be taken, even for long-duration 
outdoor activities. If a sunscreen of SPF 30 was correctly applied on days with UVI > 3, but not applied on days 
with UVI < 3, over the course of a year, the cumulative dose to the skin on the low UVI days would exceed that 
from the high UVI days by a factor of 3. Thus, the messaging unnecessarily increases risks to health, such as the 
development of skin cancer.
Advice that ‘no protection is required’ for UVI < 3 should be removed from public messaging. Furthermore, 
because skin damage depends on both the UVI and the time of exposure, that is the dose rather than the dose 
rate, behavioural messages should be further tailored to reflect the time needed, rather than having a simple 
binary message such as ‘protection required’ (for UVI ≥ 3) or ‘no protection required’ (for UVI < 3). The specific 
‘no protection’ advice should be reserved only for days where the cumulative daily total UV dose is less than the 
damage threshold (e.g., 2.5 SED for skin type II).
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